Literature DB >> 9006310

Epidemiologic study of Down syndrome in a racially diverse California population, 1989-1991.

J Bishop1, C A Huether, C Torfs, F Lorey, J Deddens.   

Abstract

The prevalence of Down syndrome was studied among all live births occurring between 1989 and 1991 in the California counties monitored by the California Birth Defects Monitoring Program. Objectives of this study were: 1) to calculate adjusted prevalence rates and quinquennial maternal age-specific risk rates of Down syndrome after adjusting for elective abortion of prenatally diagnosed fetuses; 2) to estimate the impact of prenatal diagnosis and subsequent elective abortion of affected fetuses on the observed prevalence of Down syndrome; and 3) to examine sex ratios among liveborn infants and fetuses with Down syndrome. The racial/ethnic diversity and large size of the population allowed the data to be stratified into five racial categories-Hispanics, whites, Asians, blacks, and others. For the period 1989-1991, the observed prevalence of Down syndrome was 1.13 per 1,000 live births, and the adjusted total prevalence, which took into account the termination of affected pregnancies following prenatal diagnosis, was 1.53 per 1,000 live births. In a comparison of quinquennial maternal age-specific risk rates of Down syndrome by race, Hispanics and whites were the only groups with rates that differed significantly from each other, with Hispanics exhibiting higher rates at maternal ages under 40 years. The overall reduction in live births with Down syndrome in 1989-1991 that could be attributed to prenatal diagnosis and elective abortion of affected fetuses was 25.8%, with a 49.1% reduction being observed at maternal ages > or = 35 years. In 1990-1991, Hispanics had the lowest overall reduction (10.0%), while whites had the highest reduction (46.3%). The male: female ratios among liveborns with Down syndrome were significantly higher than those among all live births, and race had a significant association with sex ratios in both cases and controls. These findings indicate that prenatal diagnosis and elective termination of affected pregnancies has had a substantial impact in reducing the number of liveborns with Down syndrome in the monitored California counties. The effect was greatest for whites and least for Hispanics, with results indicating considerable variation in the use of prenatal diagnostic services among racial/ethnic groups. Estimates of adjusted total prevalence and reduction in live births with Down syndrome in this study should be considered minimal because of some underascertainment of prenatally diagnosed cases.

Entities:  

Mesh:

Year:  1997        PMID: 9006310     DOI: 10.1093/oxfordjournals.aje.a009084

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  30 in total

1.  Ethnic differences in the impact of advanced maternal age on birth prevalence of Down syndrome.

Authors:  B Khoshnood; P Pryde; S Wall; J Singh; R Mittendorf; K S Lee
Journal:  Am J Public Health       Date:  2000-11       Impact factor: 9.308

2.  International variation in reported livebirth prevalence rates of Down syndrome, adjusted for maternal age.

Authors:  A D Carothers; C A Hecht; E B Hook
Journal:  J Med Genet       Date:  1999-05       Impact factor: 6.318

3.  Male partners' role in Latinas' amniocentesis decisions.

Authors:  Carole H Browner; H Mabel Preloran
Journal:  J Genet Couns       Date:  1999-04       Impact factor: 2.537

4.  Socioeconomic barriers to informed decisionmaking regarding maternal serum screening for down syndrome: results of the French National Perinatal Survey of 1998.

Authors:  Babak Khoshnood; Béatrice Blondel; Catherine de Vigan; Gérard Bréart
Journal:  Am J Public Health       Date:  2004-03       Impact factor: 9.308

5.  Twenty-year trends in the prevalence of Down syndrome and other trisomies in Europe: impact of maternal age and prenatal screening.

Authors:  Maria Loane; Joan K Morris; Marie-Claude Addor; Larraitz Arriola; Judith Budd; Berenice Doray; Ester Garne; Miriam Gatt; Martin Haeusler; Babak Khoshnood; Kari Klungsøyr Melve; Anna Latos-Bielenska; Bob McDonnell; Carmel Mullaney; Mary O'Mahony; Annette Queisser-Wahrendorf; Judith Rankin; Anke Rissmann; Catherine Rounding; Joaquin Salvador; David Tucker; Diana Wellesley; Lyubov Yevtushok; Helen Dolk
Journal:  Eur J Hum Genet       Date:  2012-06-20       Impact factor: 4.246

6.  Sex ratio among childhood cancers by single year of age.

Authors:  Lindsay A Williams; Michaela Richardson; Erin L Marcotte; Jenny N Poynter; Logan G Spector
Journal:  Pediatr Blood Cancer       Date:  2019-02-28       Impact factor: 3.167

7.  The Incidence of Cardiac Lesions among Children with Down's Syndrome in Jamaica - A Prospective Study.

Authors:  C Scott; M Thame
Journal:  West Indian Med J       Date:  2015-08-26       Impact factor: 0.171

8.  Advances in medical technology and creation of disparities: the case of Down syndrome.

Authors:  Babak Khoshnood; Catherine De Vigan; Véronique Vodovar; Gérard Bréart; François Goffinet; Béatrice Blondel
Journal:  Am J Public Health       Date:  2006-10-31       Impact factor: 9.308

9.  Trends in survival among children with Down syndrome in 10 regions of the United States.

Authors:  James E Kucik; Mikyong Shin; Csaba Siffel; Lisa Marengo; Adolfo Correa
Journal:  Pediatrics       Date:  2012-12-17       Impact factor: 7.124

10.  Racial/ethnic differences in hospital use and cost among a statewide population of children with Down syndrome.

Authors:  Taletha Mae Derrington; Milton Kotelchuck; Katrina Plummer; Howard Cabral; Angela E Lin; Candice Belanoff; Mikyong Shin; Adolfo Correa; Scott D Grosse
Journal:  Res Dev Disabil       Date:  2013-07-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.